Business
Burcon Announces Fiscal 2025 Results and Reviews Operations
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - Burcon NutraScience Corporation (...
About this update from Burcon Nutrascience Corporation
[{"type":"text","content":"Burcon Announces Fiscal 2025 Results and Reviews OperationsVancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (\"Burcon\" or the \"Company\"), a global technology leader in plant-based protein innovation, reported results for the fiscal year ended March 31, 2025.\"Burcon is at a pivotal inflection point—transitioning from innovation to execution while continuing to lead through differentiated, best-in-class protein technologies,\" said Kip Underwood, Burcon's chief executive officer. \"We're focused on scaling production, meeting customer demand, and driving sustained commercial growth.\"Fiscal 2025 Operational Highlights:In fiscal 2025, Burcon focused on building a strong foundation for future growth—securing a direct route-to-market for its protein technologies, strengthening the balance sheet to support execution, and developing a robust customer pipeline.During fiscal 2025, Burcon:Formed a strategic alliance with Re ProMan LLC (\"ProMan\"), which completed the acquisition of the Galesburg protein production facility;Successfully closed rights offering financing with gross proceeds of $9.4 million;Launched Puratein®C canola protein, Peazazz®C pea protein and new-to-the-world Solatein™ sunflower protein;Collaborated with Puratos to pioneer new canola protein applications;Received three patent grants from USPTO; andBegan trading on OTCQB Venture MarketSubsequent to the year-end, Burcon:Achieved first commercial production of pea protein; andEntered into $6.8 million multi-year production agreementManagement CommentaryFiscal 2025 marked a transformative year for Burcon, as we successfully laid the foundation for our long-term growth and commercial success. The year's most significant milestone was forming a strategic alliance with ProMan, which led to the acquisition of the Galesburg production facility. This achievement established a direct route-to-market for our innovative plant-based protein technologies and positioned Burcon as a revenue-generating protein innovation company.The Galesburg facility now serves as the cornerstone of our commercialization strategy. Fully commissioned and operational, it provides the infrastructure to produce high-purity, high-performance plant proteins at scale. Our end-to-end control—fro...